A novel hepatocellular carcinoma-specific mTORC1-related signature for anticipating prognosis and immunotherapy

Tumor oncogenesis, cancer metastasis, and immune evasion were substantially impacted by the mammalian target of the rapamycin complex 1 (mTORC1) pathway. However, in hepatocellular carcinoma (HCC), no mTORC1 signaling-based gene signature has ever been published. mTORC1 scores were computed employin...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Erbao, Mo, Yuqian, Yi, Jing, Liu, Jie, Luo, Ting, Li, Zheng, Lin, Zewei, Hu, Yibing, Zou, Zhilin, Liu, Jikui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497017/
https://www.ncbi.nlm.nih.gov/pubmed/37589508
http://dx.doi.org/10.18632/aging.204862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497017/
https://www.ncbi.nlm.nih.gov/pubmed/37589508
http://dx.doi.org/10.18632/aging.204862

Ejemplares similares